Portola Pharmaceuticals, located in South San Francisco, is dedicated to making a meaningful impact for individuals living with rare diseases. Through their innovative medicines and commitment to research and development, they strive to improve health equity and transform the lives of patients and families facing rare and devastating conditions.
With a focus on rare diseases such as aHUS, GMG, HPP, LAL D, NF1, NMOSD, and PNH, Portola Pharmaceuticals works tirelessly to provide support services, develop new treatments, and give hope to those in need. Their dedication to corporate social responsibility and patient well-being drives their mission to create a brighter future for individuals living with challenging medical conditions.
Generated from the website